Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Lilly


Contact Details:
lilly corporate center
Indianapolis
IN
46285
United States of America
Tel:
Fax:
Email:

Loading...

Recent Publications by Lilly:

A Comparison of Costs among Patients with Type 2 Diabetes Mellitus Who Initiated Therapy with Exenatide or Insulin Glargine.
Exenatide (Byetta(R)) and insulin glargine (Lantus(R)) are antidiabetic...
13th November, 2009
Eli Lilly and Company, Indianapolis, Indiana, USA. Appl Health Econ Health Policy. 2009;7(4):245-54. doi:
DOI Direct Link
Letter to the editor.
Exenatide (Byetta(R)) and insulin glargine (Lantus(R)) are antidiabetic...
12th November, 2009
Elanco Animal Health, A Division of Eli Lilly and Company, Greenfield, IN Br Poult Sci. 2009 Sep;50(5):544-5.
DOI Direct Link
RNA helicase Ddx39 is expressed in the developing central nervous system, limb, otic vesicle, branchial arches and facial mesenchyme of Xenopus laevis.
Ddx39, a DEAD box RNA helicase, is a part of the homeostatic machinery...
11th November, 2009
Department of Biology, Indiana University-Purdue University Indianapolis, Gene Expr Patterns. 2009 Nov 6.
DOI Direct Link
Costs and health-related quality of life effects of hysterectomy in patients with benign uterine disorders.
Abstract Objective. To gain knowledge about the utility of hysterectomy in...
11th November, 2009
Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA. Acta Obstet Gynecol Scand. 2009 Nov 10.
Prevalence of Metabolic Syndrome in Adult Hypopituitary Growth Hormone (GH)-Deficient Patients Before and After GH Replacement.
Context and Objective: Metabolic and body compositional consequences of GH...
10th November, 2009
Cascina del Rosone (A.F.A.), 14041 Agliano Terme, Italy; Lilly Research J Clin Endocrinol Metab. 2009 Nov 6.
DOI Direct Link

View more Lilly research publications.

Press Releases on Lilly:

BioPortfolio Logo
ASTMH Symposium Showcases Efforts To Meet the Need for New Medicines to Treat Infectious Diseases in Developing Countries 21st November, 2009 The American Society of Tropical Medicine and Hygiene
-- Extending a Hand: Eli Lilly's TB Drug Discovery Partnership -- Gail H. Cassell, Eli Lilly & Co., Indianapolis, IN The aim of the symposium was to illustrate how industry
Reportlinker Adds Oncology Roadmap: Brand Spending Benchmarks and Market Forecast to 2013 20th November, 2009 Reportlinker
NEW YORK, Nov. 20 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Oncology Roadmap: Brand Spending Benchmarks and Market Forecast to 2013
VerifyNow(R) System Highlighted in POPular Study Comparing Platelet Reactivity Tests 19th November, 2009
SAN DIEGO, November 19 /PRNewswire/ -- Accumetrics, Inc., developer of the VerifyNow System, the first point-of-care method for measuring platelet reactivity, announces that its market-leading
New Updates to AHA/ACC/SCAI Clinical Guidelines Recommend Treatment with Effient(R) for Patients with Acute Coronary Syndromes Managed with PCI 18th November, 2009 Eli Lilly and Company
PARSIPPANY, N.J. and INDIANAPOLIS, Nov. 18 /PRNewswire-FirstCall/ -- Effient® (prasugrel) tablets, a new antiplatelet medicine, was added as a treatment option in two clinical guideline updates: one
Reportlinker Adds Alzheimer's and Parkinson's Diseases - A Global Update of Market Trends & Opportunities 18th November, 2009 Reportlinker
NEW YORK, Nov. 18 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Alzheimer's and Parkinson's Diseases - A Global Update of Market

BioNews Results for Lilly:

Eli Lilly Hires New Chief Researcher
Manufacturing.net:  Nov 16 2009 12:20AM Matching: lilly
Lilly's big cancer bet: seeking new blockbusters
Indy.com:  Nov 15 2009 12:35PM Matching: lilly
Lilly's big cancer bet: new blockbusters
Indianapolis Star:  Nov 15 2009 7:08AM Matching: lilly
Mercy Regional Cancer Center Hosts Lilly Oncology on Canvas Art Exhibit
Port Huron Times-Herald:  Nov 15 2009 3:37AM Matching: lilly
Deadline Extended to December 16 to Submit Nominations for Depression Awards Program
PharmiWeb:  Nov 15 2009 3:25AM Matching: lilly
Promote your company here: BioNewsCast - Press Release Distribution

View more Lilly news.

Lilly Clinical Trials:

Comparative Study of Gemcitabine,Cisplatin and Radiation Versus Cisplatin and Radiation in Cancer of the Cervix

Lilly Patents:

US Patent No.Title
7501441 Naphthyl compounds, intermediates, processes, compositions, and methods
7544812 Peroxisome proliferator activated receptor agonists
7547691 [4-(Benzo[B]thiophen-2-yl) Pyrimidin-2-yl]-amine derivatives as IKK-beta inhibitors for the treatment of cancer and inflammatory diseases
7550428 Echinocandin/carbohydrate complexes
7550434 Stabilized teriparatide solutions

View more Lilly patents.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 1317 individuals from Lilly using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 783 times since April 2007, the link to the organisation's website has been followed 0 times

Recent Search Terms used to find this page: comparing pharma pipeline 2009 lilly | fgf-21 lilly clinical trial | lilly and observational research 2009 | erl wood postcode | lilly angiox | .

Search for more companies in Indianapolis

Search for more companies in IN



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Lilly

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.